![]() |
|||||||||||
Thursday, September 30, 2004 Controversies in Thyroid Hormone Therapy Moderator: Peter A. Singer Testing the Bioavailability of Oral L-T4 Presented by: Jim Stockigt Minimally Abnormal TSH Levels: Are They Relevant? Presented by: Whitney Woodmansee Treating Children with Congenital Hypothyroidism: How Much and How Fast? Presented by: Stephen LaFranchi, MD “Early Riser” CME Symposium and breakfast supported in part by an unrestricted educational grant from Abbott Laboratories Keynote Speaker Thyroid Hormone Transport into Cells Presented by: Theo J. Visser, PhD Arthur Bauman Clinical Symposium Update on Hashimoto’s Thyroiditis Moderator: Rebecca Bahn The Hurthle Cell and Its Role in Autoimmune Thyroid Disease Presented by: Patrizio Caturegli, MD, MPH Searching for Autoimmune Thyroid Disease Susceptibility Genes Presented by: Yaron Tomer, MD Hashimoto’s Disease and the Brain: Does Hashimoto’s Encephalopathy Exist? Presented by: Robert Utiger Supported in part by an unrestricted educational grant from Monarch Pharmaceuticals and Jones Pharma, Wholly Owned Subsidiaries of King Pharmaceuticals, Inc. Symposium "An Odyssey in Thyroid Autoimmunity" Presented by: Sandra McLachlan, PhD Friday, October 1, 2004 Recent Advances in the Treatment of Thyroid Cancer Moderator: Ernest Mazzaferri Options for Ablating Thyroid Remnants Presented by: Furio Pacini, MD Thyroglobulin Levels in Thyroid Cancer: Do Supersensitive Assays Matter? Presented by: Martin Schlumberger Complications of Radioiodine Therapy in Thyroid Cancer Presented by: Stephanie Lee “Early Riser” CME Symposium and breakfast supported in part by an unrestricted educational grant from Genzyme Corporation Thyroid Nodules and Cancer Moderator: Michael Tuttle The Utility of Molecular Markers in Thyroid Neoplasms Presented by: Bryan R. Haugen, MD New Techniques in Thyroid Surgery Presented by: Randal S. Weber, MD, FACS The Utility of Blood Markers in Thyroid Cancer Presented by: Furio Pacini, MD Supported in part by an unrestricted educational grant from Genzyme, Inc. Endocrine Grand Rounds: Funky Thyroid Function Tests Moderator: Kenneth Burman, MD Presented by Panel: E. Chester Ridgway, MD Leonard Wartofsky, MD Cheryl Pickett, MD Supported in part by an unrestricted educational grant from Abbott Diagnostics Division T3 Therapy: Has Its Time Come? Moderator: Leonard Wartofsky The Role of T3 in the Treatment of Hypothyroidism Presented by: E. Chester Ridgway, MD The Role of T3 in Treatment of the Euthyroid Sick Presented by: Elaine M. Kaptein, MD The Role of T3 in Depression and Mood Modulation Presented by: James V. Hennessey, MD CME Symposium supported in part by an unrestricted educational grant from Monarch Pharmaceuticals and Jones Pharma, Wholly Owned Subsidiaries of King Pharmaceuticals, Inc. Saturday, October 2, 2004 Maternal and Fetal Hypothyroidism Moderator: Joanne Rovet, PhD Normal and Abnormal Thyroid Function During Pregnancy Presented by: Susan J. Mandel, MD, MPH Maternal Hypothyroxinemia and its Potential Maternal and Fetal-Neonatal Repercussions Presented by: Daniel Glinoer What Should the Clinician Do About Thyroid Screening in Pregnancy? Recommendations from the Consensus Conferences Presented by: Gregory A. Brent, MD Supported in part by an unrestricted educational grant from Monarch Pharmaceuticals and Jones Pharma, Wholly Owned Subsidiaries of King Pharmaceuticals, Inc. Symposium "Evolving Strategies in the Detection and Management of Thyroid Carcinoma: Past and Future Perspectives" Presented by: Paul G. Walfish, CM, MD Environmental Toxicology and Thyroid Disease Moderator: David Cooper Thyroid Disruptors, Brain Development, and the Environment Presented by: Thomas Zoeller Perchlorate Contamination and Thyroid Function Presented by: Steven H. Lamm, MD, DTPH Iodine Nutrition and the Thyroid Moderator: Lewis Braverman Assessing Iodine Status and Monitoring Progress of Iodized Salt Programs: An Update Presented by: Michael Zimmermann, MD Current Iodine Nutritional Status in the United States Presented by: Elizabeth N. Pearce, MD, MSc Effects of Iodine Intake on Autoimmune and Neoplastic Thyroid Disease Presented by: Peter Laurberg Symposium “Systems Biology” Presented by: Roger Brent, PhD Supported in part by an unrestricted educational grant from Abbott Laboratories Sunday, October 3, 2004 Symposium Difficult Diagnostic and Management Issues in Hypothyroidism A Case Based Approach Moderator: Michael McDermott Presented by Panel: Paul W. Ladenson, Carol Greenlee, Leonidas Duntas
|
|||||||||||